BioCentury
ARTICLE | Clinical News

Betmiga mirabegron regulatory update

September 15, 2014 7:00 AM UTC

Germany's Institute for Quality and Efficiency in Healthcare (IQWiG) said in a preliminary benefit assessment that Betmiga mirabegron from Astellas provides no additional benefit over appropriate comp...